Indian, U.S. Generic Cos Launch 'Coalition for Affordable Care'

“The plain fact remains that the United States and India must work together to develop healthcare delivery models that provide access – not only for our own populations but for all humanity – or else peace and stability will be compromised worldwide.

“It is in our shared interest to be working together on healthcare; the United States and India must partner in this noble effort,” said Somers, former president of U.S.-India Business Council.

India First Group’s mission will be to mobilise like- minded constituents who support access to low cost, high quality alternatives to what has become a cocktail of unaffordable branded medicines, the media note said.

Because of the excessive, high price of these medicines, treatment for most of the world’s population is now beyond the reach of even the common man, it said.

“With more and more American ‘Baby-Boomers’ requiring access to lower cost, high quality medical treatments and medicines, they join most of the world’s population – some five billion people – finding themselves unable to afford even basic care,” Somers said.

“The time has come to let the truth be known on Capitol Hill, in the halls of government, and across America, that Indian and U.S. manufacturers of generic drugs are producing high quality medicines at a fraction of the price of branded pharmaceuticals,” he asserted.

“Short-sighted tactics and negative campaigns may have worked to preserve market share for these special interests previously, but history is not on their side,” Somers added.

READ MORE: Six Cars in 5 months: The Aggressive Maruti AND

 Wealthy States Guiding India Towards Prosperity